Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (51-60 of 266) with videos related to

Pageof 27
Sort By:
Blood|November 15, 2003
Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cellsMartin R Müller, Garyfalia Tsakou, Frank Grünebach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gammaAlessio Nencioni, Frank Grünebach, Anke Zobywlaski, et al.
Advanced Drug Delivery Reviews|November 6, 2007
Immunotherapy with dendritic cells for cancerAlberto Ballestrero, Davide Boy, Eva Moran, et al.
Ultrasound in Medicine & Biology|March 20, 2023
The Current Situation of Musculoskeletal Ultrasound Education: A Systematic Literature ReviewRicarda Neubauer, Florian Recker, Claus Juergen Bauer, et al.
Rheumatology International|August 27, 2024
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reportsChristian R Klein, Annkristin Heine, Peter Brossart, et al.
Hematology (Amsterdam, Netherlands)|September 22, 2023
Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)Michael Serries, Hannah Zenzen, Mario Heine, et al.
Therapeutic Advances in Musculoskeletal Disease|April 29, 2021
Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysisSophia H Verspohl, Tobias Holderried, Charlotte Behning, et al.
Oncology Research and Treatment|September 13, 2021
Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single-Center AnalysisKarin Mayer, Wibke Briese, Johannes Blieninger, et al.
Blood|October 24, 2002
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNACaterina Milazzo, Volker L Reichardt, Martin R Müller, et al.
Oncotarget|October 21, 2022
Nectin-4 is widely expressed in head and neck squamous cell carcinomaChristine Sanders, Jan-Frederic Lau, Dimo Dietrich, et al.
Pageof 27

Showing results (51-60 of 266) with videos related to

Sort By:
Pageof 27
Blood|November 15, 2003
Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cellsMartin R Müller, Garyfalia Tsakou, Frank Grünebach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gammaAlessio Nencioni, Frank Grünebach, Anke Zobywlaski, et al.
Advanced Drug Delivery Reviews|November 6, 2007
Immunotherapy with dendritic cells for cancerAlberto Ballestrero, Davide Boy, Eva Moran, et al.
Ultrasound in Medicine & Biology|March 20, 2023
The Current Situation of Musculoskeletal Ultrasound Education: A Systematic Literature ReviewRicarda Neubauer, Florian Recker, Claus Juergen Bauer, et al.
Rheumatology International|August 27, 2024
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reportsChristian R Klein, Annkristin Heine, Peter Brossart, et al.
Hematology (Amsterdam, Netherlands)|September 22, 2023
Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)Michael Serries, Hannah Zenzen, Mario Heine, et al.
Therapeutic Advances in Musculoskeletal Disease|April 29, 2021
Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysisSophia H Verspohl, Tobias Holderried, Charlotte Behning, et al.
Oncology Research and Treatment|September 13, 2021
Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single-Center AnalysisKarin Mayer, Wibke Briese, Johannes Blieninger, et al.
Blood|October 24, 2002
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNACaterina Milazzo, Volker L Reichardt, Martin R Müller, et al.
Oncotarget|October 21, 2022
Nectin-4 is widely expressed in head and neck squamous cell carcinomaChristine Sanders, Jan-Frederic Lau, Dimo Dietrich, et al.
Pageof 27